V ery low birth weight (VLBW) infants (birth weight [BW] <1500 g) represent only 1.5% of all live births in the US, 1 but the cost of neonatal intensive care unit (NICU) hospitalizations for this group ranks them among the most expensive of all patients. These costs are roughly $13.4 billion annually, accounting for 30% of newborn health care costs in the US. [2] [3] [4] (Note: Throughout this article, costs are reported in 2009 US dollars using the 2009 Consumer Price Index.) The average NICU hospitalization for VLBW infants is 57.5 days.
2 NICU hospitalization costs are higher for surviving infants, given that most nonsurviving VLBW infants die during the first 2 weeks of life, [5] [6] [7] [8] and both length of stay (LOS) and costs vary inversely with BW and gestational age (GA) in infants who survive NICU hospitalization.
These BW-and maturity-related health care costs are further increased by the fact that surviving VLBW infants are susceptible to numerous costly and potentially preventable morbidities that often require additional treatments, such as ventilation and surgery. [9] [10] [11] These morbidities not only increase NICU hospitalization costs, but also increase the risk of long-term chronic illness, rehospitalization, and developmental delay, [12] [13] [14] [15] and thus have lifelong economic consequences for society at large. [16] [17] [18] [19] [20] [21] Few studies to date have examined how these morbidity-related costs impact total costs borne by hospitals. Moreover, these studies performed only limited economic analyses, reporting only charges or adjusted charges using ratio of cost-to-charges instead of reporting actual costs borne by the hospitals. 2, 10, 11, 19, 20, [22] [23] [24] [25] In the present study, we used microlevel cost data to more precisely determine the direct costs associated with the morbidities of brain injury (defined as intraventricular hemorrhage [IVH] , periventricular leukomalacia [PVL] , or acquired hydrocephalus 12 ), necrotizing enterocolitis (NEC), bronchopulmonary dysplasia (BPD), and late-onset sepsis in surviving VLBW infants. Quantifying the direct costs will allow evaluation of the potential cost savings of therapies targeted at preventing these morbidities. 15 (other premature infants; <1500 g). We excluded infants who died during the initial NICU hospital stay, given that most nonsurviving VLBW infants die during the first 2 weeks of life, before some of the morbidities evaluated here can be diagnosed. 5, 6, 8 We also excluded infants born at or transferred to another hospital, because of incomplete cost data. In addition, infants with missing race/ethnicity or ICD-9-CM diagnosis code for GA were excluded. This study was approved by Rush University's Institutional Review Board.
Clinical and economic data were retrieved from Rush University Medical Center's system-wide data and cost accounting systems. These data comprised detailed patientlevel billing data, ICD-9-CM diagnosis codes, and clinical data extracted from the electronic medical record and associated data systems. The institution's cost accounting system reports the direct cost for each chargeable item (eg, room and board, personnel excluding physicians, drugs, medical and nonmedical supplies, equipment) used during each infant's hospital stay. The system also reports payments for the infant's hospital stay. A coexisting research database of these same surviving VLBW infants was used to determine the stage of NEC and treatment provided.
Neonatal Morbidities
Neonatal morbidities were identified using principal and secondary ICD-9-CM diagnosis codes documented by the attending neonatologist. NEC was diagnosed when an infant demonstrated both clinical (abdominal distention, feeding intolerance, bloody stool, abdominal tenderness, or bilious residuals) and radiologic (pneumatosis intestinalis, portal venous gas, or pneumoperitoneum) features of NEC. Each case was reviewed and confirmed by one of the investigators (A.P.), including cases with a nonspecific NEC diagnosis code. Cases of spontaneous intestinal perforation were not included in the NEC cases. The primary analysis combined medically and surgically managed NEC, and then a secondary analysis examined these cases separately, because surgically managed cases represent infants with more severe NEC. 13 BPD was coded by the attending neonatologist once the infant met the minimum criteria for mild BPD (ie, treatment with supplemental oxygen for 28 days but not at 36 weeks postmenstrual age [PMA] ) based on the National Institute of Child and Human Development's classification scheme of mild, moderate (need for <30% oxygen at 36 weeks PMA), and severe BPD (need for $30% oxygen or positive pressure at 36 weeks PMA). 27 Further clinical data to subdivide these infants into severity groups were not available for this study. Late-onset sepsis was diagnosed when an infant aged >72 hours presented with clinical signs and symptoms (eg, apnea and bradycardia, increased respiratory distress, hypothermia, lethargy, pallor, feeding intolerance, hemodynamic instability) and laboratory test results (eg, leukocytosis with elevated immature cells, leukopenia, neutropenia, thrombocytopenia, elevated C-reactive protein) consistent with sepsis and received antibiotic treatment for a minimum of 5 days. Infants with negative blood cultures were classified as culture-negative sepsis if no other cause could be confirmed; for example, a confirmed case of NEC would not be diagnosed as sepsis with negative culture. Further clinical data to subdivide these infants into culture-positive and culture-negative groups were not available for this study. We used a dichotomous variable to indicate the presence or absence of each morbidity, as well as a variable to indicate the total number of unique morbidities (range, 0-4). 
BW, GA, and Sociodemographic Characteristics

Direct Costs
For this study, hospital direct costs were the sum of the actual direct costs for each chargeable item (eg, electrolyte panel, room charges) incurred during the infant's hospital stay. Because physician fees were billed separately by the medical group rather than the hospital, physician fees were excluded from the hospital direct costs. Other ancillary staff costs, (eg, respiratory therapy, nursing, physical therapy, occupational therapy) were billed directly by the hospital and were included in the hospital direct costs.
Hospital direct costs were adjusted to year 2009 US dollars using the Bureau of Labor Statistics 2009 Consumer Price Index for urban consumers and all items. 4 Because costs for the Chicago metropolitan area are higher than the nationwide average, we deflated costs to reflect national average costs using the Centers for Medicare and Medicaid Services Occupational Mix Adjusted Wage Index for 2012.
Statistical Analyses
Frequencies and descriptive statistics were used to describe the sample. A generalized linear regression model was THE JOURNAL OF PEDIATRICS www.jpeds.com Vol. -, No. -constructed to model the impact of the 4 morbidities on costs, controlling for BW, GA, and infant sociodemographic characteristics (sex, race/ethnicity, and primary payer). The regression model was fit with a log-link function and gamma distribution. A modified Park test was used to select the appropriate distribution for the mean-variance relationship in each model. 28 The marginal economic effect for each morbidity was computed for the mean predicted direct cost from the model. Marginal effects were then computed separately for infants with BW <750 g, 750-999 g, 1000-1249 g, and 1250-1499 g using the modal characteristics (Medicaid, male, African-American race/ethnicity, and <25 weeks GA for BW <750 g, 25-26 weeks GA for BW 750-999 g, 27-28 weeks GA for BW 1000-1249 g, and 29-36 weeks GA for BW 1250-1499 g). 29 A critical P value of .05 was used for all tests of statistical significance. All analyses were performed using SAS for Windows version 9.2 (SAS Institute, Cary, North Carolina).
Results
Of the 587 VLBW infants born at the study site, 475 (81%) were born alive and 467 (98%) survived to discharge. Of the 467 infants who were discharged alive, 27 (6%) had missing race/ethnicity data and 15 (3%) had missing GA data. Thus, our study sample comprised 425 VLBW infants with complete data available. The study sample was 51% males with a racial/ethnic distribution of 43% African-Americans, 32% Hispanic, and 16% non-Hispanic Caucasian. Table I reports the sociodemographic characteristics, number of morbidities, and economic outcomes for the sample.
Table II presents the frequency of the 4 morbidities examined, and compares LOS and the number of additional morbidities in infants with (present) and without (absent) each of these 4 morbidities. The presence of each morbidity was associated with a longer LOS and a greater number of additional morbidities. Costs were significantly greater in infants with these morbidities. Differences in the unadjusted direct costs for the presence versus the absence of each morbidity were sizeable: 1.6 times higher for brain injury, 1.4 times higher for NEC, 2.3 times higher for BPD, and 1.4 times higher for late-onset sepsis.
Each of the 4 morbidities, after adjusting for potential confounders (BW, GA, race/ethnicity, sex, and primary payer), translated into higher marginal direct costs (Table III) . Because surgery is a major contributor to the costs of hospitalization for infants with NEC, we performed a secondary analysis to examine the separate effects of medically and surgically managed NEC. The average direct costs were $133 888 AE $26 696 for surgically managed NEC, compared with $90 209 AE $40 594 for medically managed NEC. After adjusting for the foregoing confounders, surgically managed NEC increased direct costs by $22 328 (P = .039) and medically managed NEC increased direct costs by $13 136 (P = .034) compared with infants without NEC. In addition, because IVH grades 1 and 2 are considered mild and require little additional medical treatment, we conducted a secondary analysis of severe brain injury that included only IVH grades 3 and 4, PVL, and acquired hydrocephalus. In this analysis, the presence of severe brain injury was associated with $16 103 (P = .027) in additional direct costs, after controlling for the foregoing confounders.
Using the coefficients from the regression model for direct costs, we computed the marginal effects for each morbidity separately for infants in each BW category for the modal sociodemographic characteristics (African-American/black, male, and Medicaid) and modal GA (<25 weeks GA for BW <750 g, 25-26 weeks GA for BW 750-999 g, 27-28 weeks GA for BW 1000-1249 g, and 29-36 weeks GA for BW 1250-1499 g) (Figure) . We computed direct costs for 6 hypothetical morbidity scenarios: no morbidities; individually for each of the 4 morbidities, assuming that no other morbidities were present; and all 4 morbidities present together. The marginal effects on direct costs for each of the morbidities and for all 4 morbidities together were the greatest in infants with BW <750 g.
We also examined the marginal effect of the morbidity burden by calculating the direct costs associated with the presence of an additional morbidity, without regard for which specific morbidity. After controlling for the same potential confounders, the marginal effect of each additional morbidity was a $16 543 increase in direct costs (P < .001).
Discussion
This study provides collective estimates of the direct costs incurred during NICU hospitalization for 4 morbidities in surviving VLBW infants. Our results indicate that both the presence and the number of morbidities are associated with significantly higher NICU costs, even after controlling for BW, GA race/ethnicity, sex, and primary payer. Our findings are similar to those of 4 previous studies that separately examined the costs associated with late-onset sepsis 10 and NEC 11, 25 (Table IV ; available at www.jpeds.com) and reported significantly higher NICU costs for infants with these morbidities. However, those studies used different methods to calculate costs than we did, which likely explains the differences in dollar amounts reported for the same morbidities, even after all figures are adjusted to 2009 US dollars.
Payne et al 10 reported the highest incidence of nosocomial bloodstream infection (late-onset sepsis) in infants with BW >750-1000 g ($16 068 in 2009 dollars). In contrast, our data show the highest direct costs for late-onset sepsis in infants with BW <750 g ($23 317) and the lowest costs in infants with BW 750-999 g ($2994). There are 4 major differences between our study and that of Payne et al. First, our study based the definition of late-onset sepsis on ICD-9-CM diagnosis codes that included both culture-positive and clinically diagnosed septicemia, whereas Payne et al included only infants with culture-positive septicemia. However, because the course of treatment is similar for culture-positive and clinically diagnosed septicemia, this difference likely had only a minimal impact on resource use and costs. A second major difference is that Payne et al included ventilation use as a potential confounder in their regression model but we did not, given that the presence of both septicemia and NEC increases the likelihood for ventilation use, which is costly. Because infants with BW <750 g are more likely to need mechanical ventilation and to do so for a longer period than infants with BW 750-1499 g, controlling for ventilation as a potential confounder might account for some of costs that are ultimately attributable to the morbidities themselves. Thus, the exclusion of ventilation use in our regression model might explain the differences in relative costs for the 2 BW groups between our study and that of Payne et al.
A third major difference is that we used microlevel cost data from our cost accounting system to calculate the direct costs of hospital care, whereas Payne et al estimated costs from charge data, using the costs-to-charges ratio approach. Specifically, our findings reflect all hospital resources (excluding physician fees) used to provide direct care, with the total direct costs calculated by summing the actual costs for each resource used during an infant's hospitalization. In contrast, the costs-to-charges ratio approach used by Payne et al estimates direct costs by adjusting department-level ratios of costs to charges. This commonly used approach is less accurate, because it does not reflect the actual cost of each resource used and because hospital charges are not necessarily set to reflect a constant relationship with costs across resources or across time, even within the same hospital. Finally, whereas Payne et al used multiple linear regression with a log transformation of costs, we analyzed our data using generalized linear regression models, which are a better fit for skewed data. 28 These methodological differences and a time span of a decade between the 2 studies may explain the differences in results.
Bisquera et al 11 reported that the unadjusted charges (adjusted to 2009 US dollars) were $106 685 higher for infants with medical NEC than for those without NEC. This difference increased to $269 536 for infants with surgical NEC compared with those without NEC. Although our data also show increased costs associated with NEC, our adjusted differences in charges are smaller, $96 902 for infants with medical NEC and $153 855 for those with surgical NEC compared with The number of additional morbidities is the number of additional morbidities present, excluding the specific morbidity compared; for example, the number of additional morbidities for infants with and without brain injury includes NEC, chronic lung disease, and late-onset sepsis. *P < .001. †P < .01. zP < .05.
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Vol. -, No. -infants without NEC (data not shown). The discrepancy between our findings and those reported by Bisquera et al may be related to the fact that their charges were generated between 1992 and 1994 and were not adjusted for potential confounders. In addition, our data show that infants with NEC also have more morbidities than those without NEC (Table II) , and our cost calculations adjusted for the presence or absence of other morbidities, whereas Bisquera et al did not include other morbidities in their analysis. Finally, Bisquera et al's comparison of charges instead of direct costs is problematic as a measure of costs, because each hospital establishes its own charges, which do not reflect "market prices." In a study in California, Ganapathy et al 25 reported that medically managed NEC was associated with a $70 592 increase in costs and surgically managed NEC with a $188 910 increase in costs (adjusted to 2009 US dollars) in extremely preterm infants (#28 weeks GA). Our reported increases are substantially smaller, with adjusted differences in costs of $13 923 for medically managed NEC and $22 359 for surgically managed NEC for infants #28 GA (data not shown). Even though Ganapathy et al adjusted for several clinically relevant factors, unlike us they did not control for BW or GA, which are significant predictors of costs. Differences between the 2 studies also might be related to differences in sample inclusion criteria and statistical methodology, as well as to Ganapathy et al's use of costs-to-charges ratios, although this is difficult to ascertain based on the information available.
We found substantial differences among morbidities in terms of absolute economic impact on hospital direct costs ( Table III) . The marginal impact on direct costs ranged from $10 055 for late-onset sepsis to $31 565 for BPD. Of the 4 morbidities, BPD had the highest associated mean marginal costs, especially for infants with BW <750 g, in whom costs were $43 312 higher than in infants without BPD. This is likely related to the fact that BPD is defined by the need for resources at specific time points during NICU hospitalization. Thus, by definition, infants who develop BPD require more costly resources (eg, oxygen, continuous positive airway pressure, mechanical ventilation). This is true not only at the time of diagnosis, but also earlier during the NICU hospitalization, because VLBW infants with BPD receive a longer duration of mechanical ventilation after birth compared with VLBW infants without BPD. 30 This could be further examined by evaluating costs associated with different degrees of BPD severity 27 or by confirming the diagnosis of BPD based on a physiological definition. 31 Our findings underscore the importance of identifying strategies to prevent this costly morbidity.
Limitations of the present study include the identification of neonatal morbidities using ICD-9-CM diagnosis codes assigned by the attending neonatologist, with the exception of NEC, which was confirmed by one of the investigators. This database provided detailed economic data but only limited clinical data, thereby limiting our ability to perform more detailed analyses, such as grouping infants by severity of BPD. However, because the diagnoses were made by the attending neonatologist, we believe that the ICD-9-CM codes are reasonably reliable indicators of the infants' NICU hospitalization. We hope to address this limitation in future studies that combine a robust clinical database with detailed economic data. A total of 62 073 VLBW infants were born in the US in 2008. Based on a 15% in-hospital mortality rate, 32 our estimates suggest total direct costs of approximately $4 billion (62 072 infants born alive multiplied by 85% survival rate multiplied by $76 224 in total direct costs) for hospital care during the initial NICU hospitalization alone. This figure is an underestimate of the total costs incurred during the initial NICU hospitalization, because physician costs were excluded from our analysis. In addition to incurring higher costs during NICU hospitalization, these morbidities significantly increase the risk of long-term chronic illness, rehospitalization, and developmental delay, and frequently require additional educational resources, leading to lifelong economic consequences for society. [12] [13] [14] [15] In a study of thelong-term economic consequences of preterm birth, Mangham et al 33 found that NICU hospitalization costs represent the largest share of incremental costs to society for very preterm and extremely preterm infants who survive to age 18 years compared with term-born survivors. More work is needed to understand how the morbidities evaluated in the present study impact the trajectory of costs over childhood for VLBW infants. It is critical that this future work examine the impact of these morbidities over childhood, either by modeling of the long-term health, healthcare, and cost consequences of these morbidities or through a longterm observational study that measures health, healthcare, and cost consequences over time. Our findings add to the knowledge base by determining the actual incremental cost of these morbidities to hospitals and can inform future studies evaluating interventions to prevent or reduce the incidence of these costly morbidities in surviving VLBW infants. n 
